| 1 |
35631517 | SRC Kinase-Mediated Tyrosine Phosphorylation of TUBB3 Regulates Its Stability and Mitotic Spindle Dynamics in Prostate Cancer Cells. | 2022 Apr 25 |
2 |
| 2 |
32522106 | Association of high TUBB3 with resistance to adjuvant docetaxel-based chemotherapy in gastric cancer: translational study of ITACA-S. | 2021 Apr |
3 |
| 3 |
33771409 | TUBB3 is associated with PTEN, neuroendocrine differentiation, and castration resistance in prostate cancer. | 2021 Jun |
1 |
| 4 |
31479512 | Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD-L1 expression in cancer patients. | 2020 Jun 1 |
1 |
| 5 |
32585672 | TUBB3 Is Associated with High-Grade Histology, Poor Prognosis, p53 Expression, and Cancer Stem Cell Markers in Clear Cell Renal Cell Carcinoma. | 2020 |
1 |
| 6 |
31635323 | EP4 and Class III β-Tubulin Expression in Uterine Smooth Muscle Tumors: Implications for Prognosis and Treatment. | 2019 Oct 18 |
3 |
| 7 |
31658275 | Class III β-tubulin expression as a predictor of docetaxel-resistance in metastatic castration-resistant prostate cancer. | 2019 |
1 |
| 8 |
29339176 | The absence of class III β-tubulin is predictive of a favorable response to nab-paclitaxel and gemcitabine in patients with unresectable pancreatic ductal adenocarcinoma. | 2018 Apr |
2 |
| 9 |
29491095 | Expression of Class III Beta-tubulin Predicts Prognosis in Patients with Cisplatin-resistant Bladder Cancer Receiving Paclitaxel-based Second-line Chemotherapy. | 2018 Mar |
2 |
| 10 |
30126203 | Genetics and Expression Profile of the Tubulin Gene Superfamily in Breast Cancer Subtypes and Its Relation to Taxane Resistance. | 2018 Aug 18 |
3 |
| 11 |
28521419 | Expression of excision repair cross-complementation group 1 and class III β-tubulin in thymic carcinoma. | 2017 May |
1 |
| 12 |
29022485 | Prevalence of βIII-tubulin (TUBB3) expression in human normal tissues and cancers. | 2017 Oct |
1 |
| 13 |
29383151 | High protein and mRNA expression levels of TUBB3 (class III ß-tubulin) are associated with aggressive tumor features in esophageal adenocarcinomas. | 2017 Dec 29 |
1 |
| 14 |
26426765 | Decreased expression of class III β-tubulin is associated with unfavourable prognosis in patients with malignant melanoma. | 2016 Feb |
2 |
| 15 |
25661915 | [TUBB3 role in the response of tumor cells to epothilones and taxanes]. | 2015 Jan 28 |
1 |
| 16 |
26198101 | Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer. | 2015 Jul 23 |
5 |
| 17 |
26406408 | Clinicopathological significance of β -tubulin isotype III gene expression in breast cancer patients. | 2015 |
3 |
| 18 |
24705847 | The prognostic role of the class III β-tubulin in non-small cell lung cancer (NSCLC) patients receiving the taxane/vinorebine-based chemotherapy: a meta-analysis. | 2014 |
7 |
| 19 |
22358390 | The role of βIII-tubulin in non-small cell lung cancer patients treated by taxane-based chemotherapy. | 2013 Jun |
2 |
| 20 |
23583215 | Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone. | 2013 Jul |
1 |
| 21 |
23585021 | Tubulin-β-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones. | 2013 Jul 15 |
1 |
| 22 |
23941826 | A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro. | 2013 Dec 1 |
1 |
| 23 |
24053422 | Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer. | 2013 Sep 23 |
2 |
| 24 |
22159867 | Transcriptional and post-transcriptional regulation of βIII-tubulin protein expression in relation with cell cycle-dependent regulation of tumor cells. | 2012 Mar |
1 |
| 25 |
21289518 | Expression of excision repair cross-complementation group 1, breast cancer susceptibility 1, and β III-tubulin in thymic epithelial tumors. | 2011 Mar |
2 |
| 26 |
21999149 | Class III β-tubulin (TUBB3): more than a biomarker in solid tumors? | 2011 Dec |
1 |
| 27 |
20403547 | [Class III beta tubulin expression in nonsmall cell lung cancer]. | 2010 Apr |
1 |
| 28 |
20534991 | Immunohistochemical study of HER2 and TUBB3 proteins in extramammary Paget disease. | 2010 Aug |
2 |
| 29 |
21045157 | Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy. | 2010 Nov 15 |
1 |
| 30 |
22993560 | Expression of ERCC1 and class III β-tubulin is associated with the survival of resected stage III non-small cell lung cancer patients treated with induction chemoradiotherapy using carboplatin-taxane. | 2010 May |
1 |
| 31 |
19122647 | Loss of class III beta-tubulin induced by histone deacetylation is associated with chemosensitivity to paclitaxel in malignant melanoma cells. | 2009 Jun |
3 |
| 32 |
18395930 | Expression of excision repair cross-complementation group 1 and class III beta-tubulin predict survival after chemotherapy for completely resected non-small cell lung cancer. | 2008 Oct |
1 |
| 33 |
18497984 | Epigenetic modification is involved in aberrant expression of class III beta-tubulin, TUBB3, in ovarian cancer cells. | 2008 Jun |
1 |
| 34 |
19020740 | Decreased orotate phosphoribosyltransferase activity produces 5-fluorouracil resistance in a human gastric cancer cell line. | 2008 Dec |
1 |
| 35 |
17021819 | Class III beta-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site. | 2007 Jun |
1 |
| 36 |
17714470 | Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia. | 2007 Oct |
2 |
| 37 |
18157593 | [Biomarkers - the way towards individualized chemotherapy in non-small cell lung cancer (NSCLC)]. | 2007 |
1 |
| 38 |
15749640 | Expression of class III beta tubulin in non-small cell lung cancer is correlated with resistance to taxane chemotherapy. | 2005 Feb |
1 |